Articles from Astorg

Astorg, a leading pan-European private equity firm, today announced the launch of Nexpring Health (“the company”), a global MedTech company dedicated to Assisted Reproductive Technology (“ART”). Nexpring Health emerges from Astorg’s strategic acquisitions of Hamilton Thorne, Cook Medical’s Reproductive Health business, and the soon-to-be-closed acquisition of FUJIFILM Irvine Scientific’s Medical Media Business. By combining these three businesses under a common brand identity and integrated offering, Astorg establishes Nexpring Health as a global leader in ART and a trusted partner to embryologists and reproductive medicine practitioners. As part of this new chapter, the company also announced its board of directors, including the appointment of Thomas Axelsson as Non-Executive Chairman.

Astorg, a leading pan-European private equity firm, is pleased to announce the completion of its take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business (“Cook Medical RH”). Cook Medical RH brings a leading portfolio of ART consumables and equipment including ovum aspiration needles, catheters, and pipettes. Hamilton Thorne brings a leading ART portfolio of precision instruments, consumables, software, and services. Upon closing of the transactions, Hamilton Thorne is delisted from the Toronto Stock Exchange. Astorg is now bringing the two businesses together to create a new global ART MedTech company. A new brand identity for the combined business will be rolled out in 2025.